Skip to main content

Table 1 Patient and Tumor Characteristics.

From: The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study

Characteristic

N

%

Total Patients

31

100%

Patient sex

  

  Male

13

42%

  Women

18

58%

Primary Site

  

  Non-small Cell Lung

9

16%

  Sarcoma

5

9%

  Breast

4

7%

  Head and Neck

4

7%

  Colon

4

7%

  Small Cell Lung

3

5%

  Basal Cell

1

2%

  Ovarian

1

2%

Metastatic Sites

  

  Lung

19

33%

  Lymph Node

11

19%

  Osseous

11

19%

  Liver

9

16%

  Adrenal

6

10%

  Soft tissue

2

3%

Dose

  

  24 Gray

19

33%

  30 Gray

20

35%

  36 Gray

8

14%

  42 Gray

9

16%

  50 Gray

2

3%